1. Knight Cancer Institute, Oregon Health & Science University, Portland, OR;
2. Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA;
3. Centre Hospitalier de l’Université de Montréal/CRCHUM, Montréal, QC, Canada;
4. Department of Urology, University of Duisburg-Essen, Essen, Germany and Ruprecht-Karls-University, Heidelberg, Germany;
5. Department of Urology & Renal Transplantation, Yokohama City University Medical Center, Yokohama, Japan;
6. St. Mary's Hospital of Catholic University, Seoul, South Korea;
7. Centre for Personalized Nanomedicine, University of Queensland, Brisbane, Australia;
8. Spanish National Cancer Research Centre (CNIO), Madrid and Hospitales Universitarios Virgen de la Victoria y Regional de Málaga, Málaga, Spain;
9. Georges Pompidou Hopital, Paris, France;
10. Janssen Research & Development, Titusville, NJ;
11. Clinical Biostatistics, Janssen Research & Development, Titusville, NJ;
12. Janssen Research & Development, High Wycombe, United Kingdom;
13. Janssen Research & Development, Los Angeles, CA;
14. Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA;